News round-up by DDW’s Reece Armstrong for 23-27 May
UK investment plans, company appointments to drive strategy, and digital health platforms are some of the themes of this week’s news round-up.
A new £20 million fund has been launched in the Northwest of England to help support the region’s life sciences sector. The ‘GMC Life Sciences Fund By Praetura’ is a partnership between Greater Manchester Combined Authority (GMCA), Cheshire and Warrington Local Enterprise Partnership (LEP), Bruntwood SciTech and Praetura Ventures.
Biotechnology company Calidi Biotherapeutics has been granted a US patent for its SuperNova (SNV) technology platform. Calidi’s SNV platform is composed of allogeneic, adipose-derived mesenchymal stem cells (AD-MSC) loaded with an oncolytic agent.
Organ-on-a-chip Company (OOC) CN Bio has appointed a new Chief Business Officer as part of its commercial business strategy.
Digital therapeutics provider Sidekick Health has launched an integrated solution for improving the outcomes of patients with Atopic Dermatitis (AD). The product was developed in collaboration with Pfizer and will be rolled out in the UK first before being launched in other regions.
R&D cloud platform provider Benchling has launched a new artificial intelligence (AI) programme to help scientists predict 3D structures of novel proteins.